Letter: immunogenicity is not the root cause for loss of response to anti‐TNF agents in patients with IBD in TDM era

LINKED CONTENT This article is linked to Colman et al papers. To view these articles, visit https://doi.org/10.1111/apt.16733

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2022-04, Vol.55 (7), p.885-886
Hauptverfasser:	Alsoud, Dahham, Verstockt, Bram, Vermeire, Séverine
Format:	Artikel
Sprache:	eng
Schlagworte:	Gastrointestinal Agents - adverse effects Humans Immunogenicity Inflammatory Bowel Diseases - drug therapy Infliximab - therapeutic use Tumor necrosis factor Tumor Necrosis Factor Inhibitors - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	LINKED CONTENT This article is linked to Colman et al papers. To view these articles, visit https://doi.org/10.1111/apt.16733
ISSN:	0269-2813 1365-2036
DOI:	10.1111/apt.16797